Alzheimer's Disease and Cardiovascular Disease

From a Western biomedical standpoint, Alzheimer’s disease and cardiovascular disease share a common web of causation centered on vascular biology. Long before symptoms arise, hypertension, diabetes, dyslipidemia, obesity, smoking, and inactivity reshape the endothelium, stiffen small arteries, and impair neurovascular coupling. These changes reduce cerebral perfusion, disrupt the blood–brain barrier, and impede perivascular clearance of amyloid-β, while systemic inflammation and insulin resistance accelerate tau and amyloid pathology. The result is mixed neuropathology—amyloid plaques and tau tangles superimposed on microinfarcts, lacunes, and white-matter hyperintensities. Clinical cohorts and autopsy series confirm this interaction: most older adults with dementia harbor both neurodegenerative and vascular lesions. Randomized evidence supports prevention leverage at the vascular level. Intensive blood-pressure control reduces mild cognitive impairment and slows white-matter disease (SPRINT MIND), and multidomain lifestyle programs (FINGER) maintain cognition in at-risk elders. Statins remain cornerstones for ASCVD risk without harming cognition; anticoagulation in atrial fibrillation prevents strokes and may lower dementia risk. Hearing correction and sleep apnea treatment add brain-health benefits. Practically, clinicians should embed brain-protective goals into standard CVD prevention: target guideline-concordant BP and lipids, screen and treat AF and OSA, prescribe aerobic/resistance exercise and Mediterranean/MIND diets, support smoking cessation and weight control, and assess hearing. These steps yield dual gains—fewer cardiovascular events now and delayed cognitive decline later.

Eastern medical systems frame the brain–heart relationship through circulation and mind–body balance. In TCM, cognitive decline often reflects phlegm-damp obstruction and blood stasis hindering nourishment of the brain’s ‘Sea of Marrow,’ compounded by kidney essence deficiency; the Heart governs the Shen (mind), so cardiac and mental vitality are interdependent. Ayurveda similarly emphasizes rasayana (rejuvenation) and medhya (cognition) within a lifestyle matrix of diet, movement, sleep, and stress regulation. Interventions that ‘move blood and qi’ or restore balance (tai chi, qigong, yoga, breathing practices, meditation) demonstrate measurable cardiovascular benefits—lower blood pressure, improved autonomic tone and fitness—and small-to-moderate cognitive gains in older adults and post-stroke patients. Selected botanicals—Ginkgo biloba (standardized EGb 761) for cognitive symptoms, Bacopa monnieri for memory, Salvia miltiorrhiza or Terminalia arjuna for circulatory support—have emerging but heterogeneous evidence and require careful attention to dosing, product quality, and drug–herb interactions (for example, ginkgo with anticoagulants). Acupuncture may modestly reduce blood pressure and aid post-stroke cognitive rehabilitation as an adjunct. Integrated care can align Eastern modalities with Western prevention: mind–body exercise to support cardiorespiratory fitness and executive function; sleep hygiene and breathwork for autonomic balance; anti-inflammatory, plant-forward dietary principles; and cautious, practitioner-guided use of botanicals alongside standard pharmacotherapy. This culturally responsive blend aims to enhance adherence, reduce vascular stressors, and support cognitive reserve while honoring safety and evidence constraints.